Back to calendar
Fate Therapeutics, Inc. (FATE) Earnings
FATE reports earnings on Monday, November 2, 2026
earnings report
November 2, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.27
Actual EPS: $-0.25
EPS surprise: 6.46%
Company overview
Market Cap$240.8M
PriceUSD 2.01
EPS (TTM)-1.05
52-week high3.23
52-week low0.95
SectorHealth Technology
IndustryBiotechnology
Employees161